Avalon Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $208K | Sell |
3,011
-64
| -2% | -$4.42K | 0.02% | 137 |
|
2025
Q1 | $214K | Buy |
3,075
+14
| +0.5% | +$972 | 0.02% | 127 |
|
2024
Q4 | $263K | Buy |
3,061
+689
| +29% | +$59.3K | 0.02% | 111 |
|
2024
Q3 | $282K | Hold |
2,372
| – | – | 0.02% | 107 |
|
2024
Q2 | $339K | Hold |
2,372
| – | – | 0.03% | 98 |
|
2024
Q1 | $305K | Hold |
2,372
| – | – | 0.03% | 109 |
|
2023
Q4 | $245K | Hold |
2,372
| – | – | 0.02% | 112 |
|
2023
Q3 | $216K | Hold |
2,372
| – | – | 0.02% | 112 |
|
2023
Q2 | $192K | Hold |
2,372
| – | – | 0.02% | 126 |
|
2023
Q1 | $189K | Buy |
+2,372
| New | +$189K | 0.02% | 122 |
|